Search Results - "Fair, W"

Prostate-specific membrane antigen expression in normal and malignant human tissues by SILVER, D. A, PELLICER, I, FAIR, W. R, HESTON, W. D. W, CORDON-CARDO, C

“…Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium. The expression of this…”
Get full text

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer by Zelefsky, M J, Leibel, S A, Gaudin, P B, Kutcher, G J, Fleshner, N E, Venkatramen, E S, Reuter, V E, Fair, W R, Ling, C C, Fuks, Z

“…Three-dimensional conformal radiation therapy (3D-CRT) is a technique designed to deliver prescribed radiation doses to localized tumors with high precision,…”
Get more information

The treated natural history of high risk superficial bladder cancer: 15-year outcome by Cookson, M S, Herr, H W, Zhang, Z F, Soloway, S, Sogani, P C, Fair, W R

“…The long-term outcome of patients with high risk superficial bladder cancer is unknown. We report the results of 15 years of followup of high risk patients…”
Get more information

Incidence and clinical significance of false-negative sextant prostate biopsies by Rabbani, F, Stroumbakis, N, Kava, B R, Cookson, M S, Fair, W R

“…Since most patients do not undergo repeat sextant prostate biopsies after a biopsy is positive for prostate cancer, the true incidence of false-negative…”
Get more information

Pelvic lymph node dissection can be curative in patients with node positive bladder cancer by Vieweg, J, Gschwend, J E, Herr, H W, Fair, W R

“…We analyze outcome in a large cohort of patients with bladder cancer metastatic to the regional lymph nodes using disease specific survival as the end point…”
Get more information

Expression of the prostate-specific membrane antigen by ISRAELI, R. S, POWELL, T, CORR, J. G, FAIR, W. R, HESTON, W. D. W

“…We have recently cloned a 2.65-kilobase complementary DNA (cDNA) encoding the prostate-specific membrane antigen (PSM) recognized by the 7E11-C5.3…”
Get full text

Cancer of the prostate: A nutritional disease? by Fair, William R., Fleshner, Neil E., Heston, Warren

“…In summary, epidemiologic and laboratory evidence increasingly demonstrate that nutritional factors, especially reduced fat intake, soy proteins, vitamin E…”
Get full text

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression by Sarkis, A S, Dalbagni, G, Cordon-Cardo, C, Zhang, Z F, Sheinfeld, J, Fair, W R, Herr, H W, Reuter, V E

“…Approximately one third of the patients with superficially infiltrative transitional cell (T1-TNM pathological staging system) bladder carcinoma who are…”
Get more information

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer by Cordon-Cardo, C, Wartinger, D, Petrylak, D, Dalbagni, G, Fair, W R, Fuks, Z, Reuter, V E

“…It has been reported that 50%-70% of patients with bladder cancer experience recurrence after initial successful treatment and about 10%-20% of these patients…”
Get more information

Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications by Cookson, M S, Fleshner, N E, Soloway, S M, Fair, W R

“…Despite the reliability of Gleason grading with respect to the same specimen, the correlation between the biopsy and prostatectomy specimen is less well…”
Get more information

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen by ISRAELI, R. S, POWELL, C. T, FAIR, W. R, HESTON, W. D. W

“…Recently, a novel M(r) 100,000 prostate-specific membrane glycoprotein (PSM) has been detected by the prostate-specific monoclonal antibody 7E11-C5, raised…”
Get full text

Genetic alterations in bladder cancer by Dalbagni, G, Presti, J, Reuter, V, Fair, W R, Cordon-Cardo, C

“…To see whether genetic alterations follow a sequence of events leading to bladder cancer progression, 60 paired bladder tumours and normal tissues were…”
Get more information

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome by Lacombe, L, Dalbagni, G, Zhang, Z F, Cordon-Cardo, C, Fair, W R, Herr, H W, Reuter, V E

“…We have previously demonstrated that p53 overexpression is predictive of disease progression and survival in Ta, Tis, and T1 tumors. Instillation of Bacillus…”
Get more information

Clinical stage I testis cancer: long-term outcome of patients on surveillance by Sogani, P C, Perrotti, M, Herr, H W, Fair, W R, Thaler, H T, Bosl, G

“…The long-term outcome results of a prospective surveillance trial for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCT) are reported in…”
Get more information

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder by Sarkis, A S, Dalbagni, G, Cordon-Cardo, C, Melamed, J, Zhang, Z F, Sheinfeld, J, Fair, W R, Herr, H W, Reuter, V E

“…We investigated the prevalence and clinical relevance of p53 nuclear overexpression, as detected by antibody PAb1801 and immunohistochemistry, in 33 patients…”
Get more information

The impact of primary stage on survival in patients with lymph node positive bladder cancer by Vieweg, J, Gschwend, J E, Herr, H W, Fair, W R

“…Contemporary series indicate that survival of cystectomy candidates with node positive bladder cancer is favorable when the primary tumor is confined to the…”
Get more information

Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet by Wang, Y, Corr, J G, Thaler, H T, Tao, Y, Fair, W R, Heston, W D

“…Geographic variation in the incidence of clinically detected prostate cancer is considerable, with a 120-fold greater incidence in the United States than in…”
Get more information

Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice by Fleshner, N, Fair, W R, Huryk, R, Heston, W D

“…Prostate cancer has become an important public health problem in the Western world. It is currently the most common diagnosed cancer and the second leading…”
Get more information

Indications for transition zone biopsy in the detection of prostatic carcinoma by Fleshner, N E, Fair, W R

“…We determined the indications for transition zone biopsy in the detection of prostatic carcinoma. A total of 185 men underwent 204 transition zone prostate…”
Get more information

Immunotherapy of prostate cancer in the dunning rat model : use of cytokine gene modified tumor vaccines by VIEWEG, J, ROSENTHAL, F. M, BANNERJI, R, HESTON, W. D. W, FAIR, W. R, GANSBACHER, B, GILBOA, E

“…Adenocarcinoma of the prostate is the most common cancer in men. The majority of cancers are discovered once they have already metastasized, and there is no…”
Get full text